Sanofi saw the highest growth of 104% in patent filings in February and 101% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 89% and grants by 101%. GlobalData’s DataBook provides a comprehensive analysis of Sanofi‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Sanofi has been focused on protecting inventions in United States(US) with 161 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 24% filings and 28% grants. The United States(US), Japan(JP), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Sanofi is filings its patents. Among the top granted patent authorities, Sanofi has 28% of its grants in United States(US), 16% in Japan(JP) and 12% in European Patent Office(EPO).

Regeneron Pharmaceuticals and Amgen could be the strongest competitors for Sanofi

In terms of grant share, Sanofi stands in fifth position among its competitors. Regeneron Pharmaceuticals and Amgen secured the top positions according to recent patent publication data.

Patents related to rare diseases and healthtech lead Sanofi's portfolio

Sanofi has the highest number of patents in rare diseases followed by, healthtech and remote patient monitoring. For rare diseases, nearly 15% of patents were filed and 31% of patents were granted in Q1 2024.

Drug delivery devices related patents lead Sanofi portfolio followed by other remote patient monitoring, and healthcare it

Sanofi has highest number of patents in drug delivery devices followed by other remote patient monitoring, healthcare it, asthma, and atopic dermatitis (atopic eczema). For drug delivery devices, nearly 4% of patents were filed and 4% of patents were granted in Q1 2024.

For comprehensive analysis of Sanofi's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.